Navigation Links
Chinese Pharma Market Continues to Grow at a 5-7% Rate in 2009; AMDL Remains on Track to Meet FY09 Financial Targets

AMDL Inc. Executive Chairman & CEO Douglas MacLellan offers expert insight during exclusive interview with The Wall Street Transcript

TUSTIN, Calif., April 29 /PRNewswire-FirstCall/ -- AMDL Inc. (NYSE Alternext US: ADL), a US-based pharmaceutical company with major operations in China, announced today its Executive Chairman and CEO Mr. Douglas MacLellan has been interviewed and featured in The Wall Street Transcript - a New York weekly investment news publication focused on bringing market news and analysis through exclusive interviews with Wall Street professionals, industry experts and corporate executives.

In an exclusive interview, Mr. MacLellan discusses AMDL's continued focus on becoming a premier pharmaceutical company in the growing $100B China market; the Company's regional expansion and distribution strategy in China; current financing efforts and financial targets for fiscal year 2009; and AMDL's worldwide commercialization strategy for its DR-70 (FDP) cancer test and Human Placenta Extract (HPE) skin care line.

Mr. MacLellan also provided opinion on China pharmaceutical industry saying, "Since the beginning of 2009 the stock market in China has gone up 30%, while the US, European, and other Asian markets have fallen. The Chinese market is going to be the force behind AMDL's sales and marketing for the next few years ... this is good because this market continues to grow and is expected to continue growing between 5-7% from a GDP perspective in 2009."

For the past four consecutive years AMDL has achieved over 100% year-over-year gross revenue growth. Mr. MacLellan provided further insight on AMDL's tremendous growth trajectory saying the Company's FY2009 growth prospects remain strong and executive management is confident AMDL will achieve its FY09 financial guidance of US $62-74 million - which represents another year of 100% growth.

AMDL is featured as the "#1 Small-Cap Stock Pick for 2009" by Flaherty Financial News ( ), a New York-based investment newsletter, and named one of the Top 5 fastest growing publicly-traded companies in Orange County by international consulting group Deloitte.

The Wall Street Transcript executive interview of Mr. MacLellan has been published and is available on the WST website located at . For additional information on AMDL, its portfolio of international health and beauty products, and 2009 business strategy, visit the Company's website at or contact AMDL Investor Relations at .

About AMDL:

Headquartered in Tustin, CA with operations in China, AMDL Inc., along with its subsidiary Jade Pharmaceutical Inc. (JPI), is a pharmaceutical company devoted to the research, development, manufacturing, and marketing of diagnostic, pharmaceutical, nutritional supplement, and cosmetic products. The Company employs over 500 people in the US and China.

Forward Looking Statements:

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: The statements contained in this document include certain predictions and projections that may be considered forward-looking statements under securities law. These statements involve a number of important risks and uncertainties that could cause actual results to differ materially including, but not limited to, the performance of joint venture partners, as well as other economic, competitive and technological factors involving the Company's operations, markets, services, products, and prices. With respect to AMDL Inc., except for the historical information contained herein, the matters discussed in this document are forward-looking statements involving risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.

    AMDL Contact:
    Kristine Szarkowitz
    Director-Investor Relations
    (Tel:) 206.310.5323

Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Forensic Expert Investigating Chinese Drywall Issue
2. NIAID and Chinese officials sign agreement to foster TB research in Chinas Henan province
3. MIT is pleased to announce that it has received a US$ 200,000 private placement from its future Chinese partners
4. American Heart Association Web Site Now Offers Content Translated Into Traditional Chinese
5. Chinese Colorectal Cancer Drug Market Will More Than Double by 2012
6. Americas Watchdog Calls On President Obama To Get Involved With The Toxic Chinese Drywall Disaster--Now
7. Samplify Expands Global Distribution Channel; Signs Top-Ranked Chinese Distributor, Excelpoint
8. Class Action Filed Against South Florida Developer and Supplier of Defective Chinese Drywall
9. Traditional Chinese Therapy May Help Ease Eczema
10. Defective Chinese Drywall Lawsuit: Florida Homeowners' Associations and Condominium Associations Plagued by Defective Chinese Drywall Urged to Investigate their Rights
11. HUYA Bioscience International Announces Collaboration Agreement With the Beijing Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College
Post Your Comments:
(Date:11/25/2015)... Spring, Md (PRWEB) , ... November 25, 2015 ... ... Pulmonary Hypertension Association (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible ... history of this disease. The Periwinkle Pioneers, nominated by the public, will receive ...
(Date:11/25/2015)... ... November 25, 2015 , ... ... philanthropic seniors, is resulting in a way for homeless people to have a ... have launched a new initiative whereby they are repurposing plastic bags into sleeping ...
(Date:11/25/2015)... ... November 25, 2015 , ... Since its launch in ... involving adult stem cell therapies to patients with chronic degenerative medical conditions. Now, ... a Registered Trademark (RTM). , Organizations are required to hold a registered trademark ...
(Date:11/24/2015)... ... November 25, 2015 , ... Genesis Chiropractic Software helps practice ... an agreement between the practice owner and the patient that automatically manages all ... projections. Click here to learn more. , According to ...
(Date:11/24/2015)... , ... November 24, 2015 , ... New patients who ... a referral for dental implants at her Mississauga, ON practice. Dr. Williams ... in the placement of dental implants. , Missing teeth can lead to a ...
Breaking Medicine News(10 mins):
(Date:11/24/2015)... 25, 2015 WuXi PharmaTech (Cayman) Inc. ("WuXi" ... open-access R&D capability and technology platform company serving the ... China and the ... extraordinary general meeting of shareholders held today, the Company,s ... and approve the previously announced agreement and plan of ...
(Date:11/24/2015)... N.C. , Nov. 24, 2015  In the ... projects in an effort to quickly uncover new insights, ... --> --> However, ... a market research project and ensure that all rules ... and industry standards. Another major barrier to efficiently launching ...
(Date:11/24/2015)... Va. , Nov. 24, 2015  DILON Diagnostics ... have signed an agreement for DILON to distribute GE,s ... across the globe. The signing of this distribution agreement will ... NM750b Molecular Breast Imaging system and is considered an ... provide better healthcare solutions for clinicians and their patients. ...
Breaking Medicine Technology: